Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Combination ART, TB Treatment Slash Co-Infected Patient Mortality Rates, Study Finds

February 26, 2010

The initiation of antiretroviral therapy (ART) during tuberculosis (TB) therapy "significantly improves" treatment-naive, HIV-postive patient survival, a New England Journal of Medicine study finds (Karim et al., 2/25). Combined therapy in the clinical trial of 642 patients reduced mortality rates by 56 percent, according to a Columbia University press release (2/25). "[O]ur findings provide compelling evidence of the benefit of initiating antiretroviral therapy during tuberculosis therapy in patients with HIV coinfection. The findings also support recommendations by the WHO and others for the integration of tuberculosis and HIV care," the study authors concludes (2/25).

Back to other news for February 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Tuberculosis (TB) Fact Sheet
Questions and Answers About Tuberculosis
More on Treating Tuberculosis and HIV/AIDS
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement